Business
Why the Mesoblast share price jumped higher this morning – Motley Fool Australia
Today the Mesoblast share price jumped higher after the company announced a positive recommendation regarding its COVID-19 treatment trials.
This morning, the Mesoblast limited(ASX: MSB) share price jumped 3.14% to $5.25 after the company received a positive recommendation from the Data Safety Monitoring Board (DSMB) to continue its phase 3 trial of remestemcel-L in patients with acute COVID-19. The positive news, however, was not sufficient to sustain the Mesoblast share price amid wider share market falls with the company now trading at $5.04 at the time of writing.
What moved the Mesoblast share price?
The Mesoblast share pric…
-
Noosa News6 hours agoMotorcyclist dies in crash with truck
-
Noosa News5 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
General20 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News20 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
